Stimulation of nerve growth factor and substance P expression in the iris-trigeminal axis of diabetic rats - Involvement of oxidative stress and effects of aldose reductase inhibition

Brain Research

Volumn 802, Issue 1-2, 1998, Pages 247-253

  Fernyhough, Paul ^a   Brewster, Wendy J ^a   Fernandes, Karin ^a   Diemel, Lara T ^a   Tomlinson, David R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Aldose reductase; Inflammation; Nerve growth factor; Neurotrophin 3; Oxidative stress; Substance P; TrkA

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; ANTIOXIDANT; BUTYLCRESOL; CALCITONIN GENE RELATED PEPTIDE; GLUCOSE; INOSITOL; NERVE GROWTH FACTOR; NEUROTROPHIN 3; PREPROTACHYKININ; SORBINIL; SORBITOL; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME INHIBITION; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; IRIS; IRITIS; MALE; NONHUMAN; NORTHERN BLOTTING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES; TRIGEMINUS GANGLION;

ALDEHYDE REDUCTASE; ANIMALS; BLOOD GLUCOSE; CARRIER PROTEINS; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; IMIDAZOLES; IMIDAZOLIDINES; IRIS; MALE; MEMBRANE PROTEINS; MONOSACCHARIDES; NERVE GROWTH FACTORS; OXIDATIVE STRESS; POLYMERS; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RECEPTOR, TRKA; RNA, MESSENGER; SCIATIC NERVE; SUBSTANCE P; TACHYKININS; TRIGEMINAL GANGLION;

EID: 0344269341     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00638-6     Document Type: Article

References (43)

1. Y. Ala, O. Palluy, J. Favero, C. Bonne, G. Modat, J. Dornand, Hypoxia/reoxygenation stimulates endothelial cells to promote interleukin-1 and interleukin-6 production. Effects of free radical scavengers, Agents Actions 37 (1992) 134-139.
2. P. Anand, G. Terenghi, G. Warner, P.G. Kopelman, R.E. Williams-Chestnut, D.V. Sinicropi, The role of endogenous nerve growth factor in human diabetic neuropathy, Nature Med. 2 (1996) 703-707.
3. S.C. Apfel, J.C. Arezzo, M. Brownlee, H. Federoff, J.A. Kessler, Nerve growth factor administration protects against experimental diabetic sensory neuropathy, Brain Res. 634 (1994) 7-12.
4. Y.-A. Barde, Neurotrophic factors: an evolutionary perspective, J. Neurobiol. 25 (1994) 1329-1333.
5. W.J. Brewster, P. Fernyhough, L.T. Diemel, L. Mohiuddin, D.R. Tomlinson, Changes in nerve growth factor and preprotachykinin messenger RNA levels in the iris and trigeminal ganglion in diabetic rats: effects of treatment with insulin or nerve growth factor, Mol. Brain Res. 29 (1995) 131-139.
6. P. Chomczynski, N. Sacchi, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162 (1987) 156-159.
7. L.T. Diemel, W.J. Brewster, P. Fernyhough, D.R. Tomlinson, Expression of neuropeptides in experimental diabetes: effects of treatment with nerve growth factor or brain-derived neurotrophic factor, Mol. Brain Res. 21 (1994) 171-175.
8. J. Donnerer, R. Schuligoi, C. Stein, R. Amann, Up-regulation, release and axonal transport of substance P and calcitonin gene-related peptide in adjuvant inflammation and regulatory function of nerve growth factor, Regul. Pept. 46 (1993) 150-154.
9. P. Fernyhough, L.T. Diemel, W.J. Brewster, D.R. Tomlinson, Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor mRNA in streptozotocin-diabetic rats: effects of insulin treatment, Neuroscience 62 (1994) 337-344.
10. P. Fernyhough, L.T. Diemel, J. Hardy, W.J. Brewster, L. Mohiuddin, D.R. Tomlinson, Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat, Eur. J. Neurosci. 7 (1995) 1107-1110.
11. W.J. Friedman, L. Lärkfors, C. Ayer-LeLievre, T. Ebendal, L. Olson, H. Persson, Regulation of b-nerve growth factor expression by inflammatory mediators in hippocampal cultures, J. Neurosci. Res. 27 (1990) 374-382.
12. H. Funakoshi, J. Frisen, G. Barbany, T. Timmusk, O. Zachrisson, V.M.K. Verge, H. Persson, Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve, J. Cell Biol. 123 (1993) 455-465.
13. R.A. Gadient, K.C. Cron, U. Otten, Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes, Neurosci. Lett. 117 (1990) 335-340.
14. S.G. Gilbey, R.J. Guy, H. Jones, D. Vergani, P.J. Watkins, Diabetes and autonomie neuropathy: an immunological association?, Diabetic Med. 3 (1986) 241-245.
15. A.-M. Gonzalez, M. Sochor, P. McLean, The effect of an aldose reductase inhibitor (sorbinil) on the level of metabolites in lenses of diabetic rats, Diabetes 32 (1983) 482-485.
16. R.F. Grimble, Nutritional antioxidants and the modulation of inflam-mation: theory and practice, New Horiz. 2 (1994) 175-185, Review, 76 Refs.
17. R.J. Guy, F. Richards, M.E. Edmonds, P.J. Watkins, Diabetic autonomic neuropathy and iritis: an association suggesting an immunological cause, Br. Med. J., Clin. Res. Ed. 289 (1984) 343-345.
18. A.J. Harmar, V. Hyde, K. Chapman, Identification and cDNA sequence of d-preprotachykinin, a fourth splicing variant of the rat substance P precursor, FEBS Lett. 275 (1990) 22-24.
19. A.J. Harmar, J.G. Schofield, P. Keen, Cycloheximide-sensitive synthesis of substance P by isolated dorsal root ganglia, Nature 284 (1980) 267-269.
20. R. Hellweg, H.-D. Hartung, Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy, J. Neurosci. Res. 26 (1990) 258-267.
21. R. Hellweg, G. Raivich, H.-D. Hartung, C. Hock, G.W. Kreutzberg, Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy, Exp. Neurol. 130 (1994) 24-30.
22. R. Heumann, S. Korsching, C.E. Bandtlow, H. Thoenen, Changes of nerve growth factor synthesis in non-neuronal cells in response to sciatic nerve transection, J. Cell Biol. 104 (1987) 1623-1631.
23. J.S. Hothersall, R.P. Muirhead, C.E. Taylaur, R.H.V. Jones, Antioxidant status in an in vitro model for hyperglycaemic lens cataract formation: competition for available nicotinamide adenine dinucleotide phosphate between glutathione reduction and the polyol pathway, Biochem. Int. 27 (1992) 945-952.
24. J. Jakobsen, S. Brimijoin, K. Skau, P. Sidenius, D. Wells, Retrograde axonal transport of transmitter enzymes, fucose-labeled protein, and nerve growth factor in streptozotocin-diabetic rats, Diabetes 30 (1981) 797-803.
25. H. Lehrach, D. Diamond, J.M. Wozney, H. Boedtker, Ribonucleic acid molecular weight determination by gel electrophoresis under denaturing conditions: a critical reexamination, Biochemistry 16 (1977) 4743-4751.
26. D. Lindholm, R. Heumann, B. Hengerer, H. Thoenen, Interleukin 1 increases stability and transcription of mRNA encoding nerve growth factor in cultured rat fibroblasts, J. Biol. Chem. 263 (1988) 16348-16351.
27. D. Lindholm, R. Heumann, M. Meyer, H. Thoenen, Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve, Nature 330 (1987) 658.
28. R.M. Lindsay, A.J. Harmar, Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons, Nature 337 (1989) 362-364.
29. M. Mahmoudi, V.K. Lin, Comparison of two different hybridisation systems in northern transfer analysis, BioTechniques 7 (1989) 331-334.
30. P.C. Maisonpierre, M.M. Le-Beau, R. Espinosa, N.Y. Ip, L. Belluscio, S.M. de-la-Monte, S. Squinto, M.E. Furth, G.D. Yancopoulos, Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations, Genomics 10 (1991) 558-568.
31. S.O. Meakin, U. Suter, C.C. Drinkwater, A.A. Welcher, E.M. Shooter, The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor, Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 2374-2378.
32. 125I] nerve growth factor in ileal mesenteric nerves in vitro: effect of streptozotocin diabetes, Brain Res. 378 (1986) 325-336.
33. J. Scott, M. Selby, M. Urdea, M. Quiroga, G.J. Bell, W.J. Rutter, Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor, Nature 302 (1983) 538-540.
34. R. Simonelli, A. Nesti, M. Pensa, L. Romano, S. Savastano, E. Rinaldi, G. Auricchio, Lipid peroxidation and human cataractogenesis in diabetes and severe myopia, Exp. Eye Res. 49 (1989) 181-187.
35. C.C. Sweeley, R. Bentley, M. Makita, W.W. Wells, Gas-liquid chromatography of trimethylsilyl derivatives of sugars and related substances, J. Am. Chem. Soc. 85 (1963) 2497-2507.
36. B. Tesfamariam, Free radicals in diabetic endothelial cell dysfunction, Free Radical Biol. Med. 16 (1994) 383-391.
37. T. Tetsuka, L.D. Baier, A.R. Morrison, Antioxidants inhibit interleukin-1-induced cyclooxygenase and nitric oxide synthase expression in rat mesangial cells. Evidence for post-transcriptional regulation, J. Biol. Chem. 271 (1996) 11689-11693.
38. H. Thoenen, The changing scene of neurotrophic factors, Trends. Neurosci. 14 (1991) 165-170.
39. P.S. Thomas, Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose, Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 5201-5205.
40. D.R. Tomlinson, G.B. Willars, N.A. Calcutt, A.M. Compton, I.A. MacDonald, H.E. Clarke, P. Keen, Effects of sorbinil treatment in rats with chronic streptozotocin-diabetes: changes in lens and in substance P and catecholamines in the iris, Curr. Eye Res. 8 (1989) 357-363.
41. V.M.K. Verge, J.-P. Merlio, J. Grondin, P. Ernfors, H. Persson, R.J. Riopelle, T. Hokfelt, P.M. Richardson, Colocalization of NGF binding sites, trk mRNA, and low-affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF, J. Neurosci. 12 (1992) 4011-4022.
42. L.A. Yeh, M.A. Ashton, The increase in lipid peroxidation in diabetic rat lens can be reversed by oral sorbinil, Metabolism 39 (1990) 619-622.
43. M.M. Zanone, J.P. Banga, M. Peakman, M. Edmonds, P.J. Watkins, An investigation of antibodies to nerve growth factor in diabetic autonomie neuropathy, Diabetic Med. 11 (1994) 378-383.